|
In simple terms bones remodel all the time but with
osteoarthritic conditions such as bone spavin the
bone-producing cells (oesteoblasts) can't keep up
with the bone-removing cells (osteoclasts), which
can work up to ten times faster. Equidronate®
actually helps to stop the osteoclasts from continuing
to disrupt the bones within the joints. It prevents
further damage and gives the osteoblasts a chance
to catch up and repair the problem. This, in combination
with adjusting the levels of exercise, helps to harmonise
the bone adaptation needed for the horse to perform
its athletic duties.
Trials published last year show that horses suffering
lameness caused by bone spavin can show marked improvement
following treatment with an Equidronate® infusion,
in combination with controlled exercise. One in four
horses showed marked improvement; two in four showed
improvement, which, when combined with other treatment,
enabled the horse to resume former levels of activity
and one in four horses showed no response.
Ceva Animal Health has produced a range of explanatory
leaflets for horse owners on bone spavin, navicular
disease and sacroiliac disease, as well as a helpful
booklet detailing the discharge procedures for horses
that have been treated with Equidronate®. Advice
on this product must be sought from your vet.
For more information
on request from Ceva Animal Health Ltd, 90 The Broadway,
Chesham, Bucks, HP5 1EG or www.tildren.com.
|
